Simulation optimization of PSA-threshold based prostate cancer screening policies

被引:17
|
作者
Underwood, Daniel J. [1 ]
Zhang, Jingyu [2 ]
Denton, Brian T. [1 ]
Shah, Nilay D. [3 ]
Inman, Brant A. [4 ]
机构
[1] N Carolina State Univ, Edward P Fitts Dept Ind & Syst Engn, Raleigh, NC 27695 USA
[2] Philips Res N Amer, Briarcliff Manor, NY 10510 USA
[3] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN 55905 USA
[4] Duke Univ, Med Ctr, Div Urol, Durham, NC 27710 USA
基金
美国国家科学基金会;
关键词
Prostate cancer screening; Simulation optimization; Genetic algorithm; Ranking and selection; SATURATION BIOPSY; UNITED-STATES; SELECTION; PROBABILITY; MORTALITY; AUTOPSY; SUBSET; SYSTEM; IMPACT; RISK;
D O I
10.1007/s10729-012-9195-x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
We describe a simulation optimization method to design PSA screening policies based on expected quality adjusted life years (QALYs). Our method integrates a simulation model in a genetic algorithm which uses a probabilistic method for selection of the best policy. We present computational results about the efficiency of our algorithm. The best policy generated by our algorithm is compared to previously recommended screening policies. Using the policies determined by our model, we present evidence that patients should be screened more aggressively but for a shorter length of time than previously published guidelines recommend.
引用
收藏
页码:293 / 309
页数:17
相关论文
共 50 条
  • [11] PSA Screening and Prostate Cancer Mortality
    Goldstein, Mark R.
    Mascitelli, Luca
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (10):
  • [12] PSA prostate cancer screening trial
    不详
    PROSTATE CANCER AND PROSTATIC DISEASES, 2001, 4 (01) : 3 - 4
  • [13] Prostate cancer screening with PSA: "Aequanimitas"
    Sadi, Marcus V.
    INTERNATIONAL BRAZ J UROL, 2013, 39 (04): : 447 - 453
  • [14] PSA Screening and Prostate Cancer Mortality
    D'Amico, Anthony V.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (10):
  • [15] PSA screening and prostate cancer incidence
    Berman, JJ
    Moore, GW
    Alonsozana, ELC
    Brown, LA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (15): : 1155 - 1155
  • [16] PSA testing for prostate cancer screening
    Castle, Philip E.
    LANCET ONCOLOGY, 2015, 16 (01): : E2 - E3
  • [17] USE OF A 1.5 PSA THRESHOLD TO IDENTIFY INCREASED RISK FOR PROSTATE CANCER IN A SCREENING POPULATION
    Hughes, Alexa
    O'Donnell, Colin
    Tandberg, Daniel J.
    Arangua, Paul
    Crawford, E. David
    JOURNAL OF UROLOGY, 2010, 183 (04): : E665 - E666
  • [18] Re: Reconsidering Prostate Cancer Mortality - The Future of PSA Screening The future of PSA screening by reconsidering prostate cancer mortality
    Borghesi, Marco
    Suardi, Nazareno
    Terrone, Carlo
    EUROPEAN UROLOGY, 2020, 78 (06) : 929 - 929
  • [19] Unintended consequences of decreased PSA-based prostate cancer screening
    Thomas Ahlering
    Linda My Huynh
    Kamaljot S. Kaler
    Stephen Williams
    Kathryn Osann
    Jean Joseph
    David Lee
    John W. Davis
    Ronney Abaza
    Jihad Kaouk
    Vipul Patel
    Isaac Yi Kim
    James Porter
    Jim C. Hu
    World Journal of Urology, 2019, 37 : 489 - 496
  • [20] PSA based screening has significant impact on prostate cancer volume
    Steiner, H
    Berger, A
    Spranger, R
    Hager, M
    Moser, P
    Horninger, W
    Bartsch, G
    JOURNAL OF UROLOGY, 2003, 169 (04): : 427 - 427